Purchases and Sales Made in Q1 2021 in Eiger Bio Pharmaceuticals, Inc. (EIGR)
This table provides information about the institutional ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR) during Q1 2021. The information is specifically focused on institutions that hold shares of Eiger BioPharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 17, 2021
Q1 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-51.1K- 13.08% |
$431K - $647K
|
340K
$3.23M
|
|
May 17, 2021
Q1 2021
|
Man Group PLC
London, X0 |
SELL
|
- |
-53K- 81.92% |
$448K - $671K
|
11.7K
$111K
|
|
May 17, 2021
Q1 2021
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-55.4KClosed |
$467K - $701K
|
0
$0
|
|
May 14, 2021
Q1 2021
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-57.9K- 59.58% |
$488K - $733K
|
39.2K
$373K
|
|
May 12, 2021
Q1 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-57.9K- 13.41% |
$488K - $733K
|
374K
$3.55M
|
|
May 17, 2021
Q1 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-59.4K- 6.25% |
$501K - $751K
|
890K
$8.45M
|
|
May 17, 2021
Q1 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-64.9K- 26.69% |
$547K - $821K
|
178K
$1.69M
|
|
May 14, 2021
Q1 2021
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-69.3K- 27.52% |
$585K - $878K
|
183K
$1.74M
|
|
May 12, 2021
Q1 2021
|
Ubs Group Ag
|
SELL
|
- |
-85.6K- 97.23% |
$723K - $1.08M
|
2.44K
$23.2K
|
|
May 10, 2021
Q1 2021
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-109K- 80.39% |
$920K - $1.38M
|
26.6K
$252K
|
|
May 14, 2021
Q1 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-138KClosed |
$1.17M - $1.75M
|
0
$0
|
|
Apr 26, 2021
Q1 2021
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-163K- 29.44% |
$1.38M - $2.07M
|
392K
$3.72M
|